Greigite nanozyme
Greigite nanozyme has been studied in 1 paper since 2023: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jul 3, 2023: “Rescuing Nucleus Pulposus Cells From Senescence via Dual-Functional Greigite Nanozyme to Alleviate Intervertebral Disc Degeneration”.
1 paper studies it4 findingsUpdated
- 1 lab in 1 country
- Funders: Government of Jiangsu Province and 4 more
- Animals1
What did studies of Greigite nanozyme find?
4Studies of Greigite nanozyme measured 4 outcomes; the most studied are intervertebral disc degeneration (1 study), inflammation (1) and cellular senescence (1).
Intervertebral disc degeneration
downin animals1
1 study
Intervertebral disc degeneration
downin animals1
Greigite nanozyme decreases intervertebral disc degeneration.
“the dual-functional greigite nanozyme holds strong potential to reverse this process, providing a novel strategy for IVDD management”
AnimalsIVDD models
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Inflammation
downin animals1
1 study
Inflammation
downin animals1
Greigite nanozyme decreases inflammation.
“rescues NPCs from senescence and alleviated the inflammatory response”
AnimalsIVDD modelsintervertebral disc
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Cellular senescence
downin animals1
1 study
Cellular senescence
downin animals1
Greigite nanozyme decreases cellular senescence.
“rescues NPCs from senescence and alleviated the inflammatory response”
AnimalsIVDD modelsintervertebral disc
Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Mitochondrial damage
downin animals1
1 study
Mitochondrial damage
downin animals1
Greigite nanozyme decreases mitochondrial damage.
“greigite nanozyme rescues damaged mitochondrial function in IVDD models both in vitro and in vivo”
AnimalsIVDD models
Advanced science (Weinheim, Baden-Wurttemberg, Germany)